Form D · Pharmaceuticals

FST Life Sciences, Inc.

Ann Arbor, MI · CIK 0001400452

Offering snapshot reported Sep 14, 2010 · SEC filing

Reported sold
$1.08M
Offering amount: $1.34M
Investors reported
9
Form D · investor count
Minimum accepted
$10K
Reported outside-investor minimum
First sale
Jun 3, 2010
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$541K$1.08MJun 17, 2010: $707,192.00Jun 17, 2010Sep 14, 2010: $1,082,192.00Sep 14, 2010

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$707,192 → $1,082,192
  • Reported investors7 → 9

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Sep 14, 2010Amendment$1,082,192$375,000vs Jun 17, 20109SEC filing
Jun 17, 2010Initial$707,192No comparison7SEC filing
May 14, 2007PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-143634

Source: Form D, filed Sep 14, 2010. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Michael Bunker Director
Thomas Holleran Director, Executive
Andrew Mc Colm Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
201 S. Main Street Suite 900
Ann Arbor, MI, 48104